By the time many people seek specialty care, depression has already taken far more than a few difficult weeks. It may have interrupted work, strained relationships, narrowed daily routines, and made even basic decisions feel exhausting. This treatment resistant depression case study illustrates what a more individualized path can look like when standard approaches have not provided meaningful relief.
The patient story below is a composite based on common clinical patterns, not an account of one identifiable person. Every person’s history, medical needs, response to treatment, and safety considerations are different. The purpose is not to promise a particular result, but to show why a careful reassessment can be as important as the next treatment itself.
When Depression Has Not Responded
“Sarah,” a 42-year-old professional from the Quad Cities area, had lived with recurring major depression since her twenties. Over several years, she had worked with primary care and mental health providers, participated in therapy, and tried multiple antidepressant medications. Some medications reduced the sharpest edge of anxiety but left her emotionally flat. Others caused side effects she found difficult to tolerate, including sleep disruption, weight changes, and fatigue.
At the time she sought additional care, Sarah was still functioning on the surface. She was getting to work, caring for her family, and meeting obligations. But she described life as something she was forcing herself through. Her concentration was poor, she had stopped seeing friends, and mornings felt especially heavy. She also had chronic migraines and widespread muscle tension, which made it harder to separate physical discomfort from emotional distress.
This picture is common in treatment-resistant depression. The term generally refers to depression that has not improved adequately after appropriate treatment attempts, often including more than one antidepressant medication. It does not mean someone has failed treatment or that recovery is out of reach. It means the current plan deserves a closer look.
Treatment Resistant Depression Case Study: The Reassessment
A useful evaluation goes beyond counting medication trials. Sarah’s care team reviewed which medications she had taken, whether doses and treatment duration had been adequate, why each treatment was stopped, and what changes she had actually noticed. They also reviewed her therapy history, sleep quality, alcohol and substance use, hormonal factors, nutrition, medical conditions, pain symptoms, and current medications.
That process mattered because depression can be complicated by conditions that need attention in parallel. Chronic pain, untreated sleep apnea, thyroid dysfunction, nutritional deficiencies, trauma exposure, inflammatory conditions, medication effects, and bipolar-spectrum symptoms can all influence mood and treatment response. No single laboratory test or intervention explains every case, but overlooking contributing factors can leave a patient feeling as though nothing works.
Sarah did not have a simple, one-cause explanation. Her evaluation suggested a layered pattern: long-standing depression, persistent anxiety, poor restorative sleep, migraine-related pain, and a growing sense of hopelessness after years of partial responses. Her treatment plan needed to address both symptom relief and the factors making recovery harder to sustain.
Her team also completed a safety assessment. Any patient experiencing thoughts of self-harm, feeling unable to stay safe, or facing a mental health emergency needs immediate crisis support or emergency care. Specialty treatments are not a substitute for urgent intervention when safety is at risk.
Considering Ketamine and Spravato Care
After reviewing options, Sarah discussed ketamine infusion therapy and Spravato, the brand name for esketamine nasal spray. These treatments are related but not identical. Intravenous ketamine is used off label for depression in many specialty settings, while Spravato is FDA approved for treatment-resistant depression when used with an oral antidepressant and is administered under specific monitoring requirements.
The right choice depends on the person’s diagnosis, treatment history, medical history, logistics, preferences, and access to care. For some patients, Spravato may fit well within an insurance-supported pathway. For others, a clinician may determine that ketamine infusion therapy is an appropriate option after a detailed screening process. Neither approach is a quick fix, and neither is appropriate for everyone.
Sarah chose a medically supervised ketamine infusion plan after discussing potential benefits, limitations, and side effects. Her providers explained that treatments can temporarily affect perception, blood pressure, coordination, and alertness. She would need a responsible adult to drive her home, would be monitored throughout each visit, and would not be expected to make major decisions immediately after treatment.
At Quad Cities Ketamine Clinic, this type of discussion is central to individualized care. Patients deserve clarity about what a treatment may offer, what it cannot guarantee, and what support is needed around it.
What Changed During Treatment
Sarah’s first few treatments were not dramatic in the way she had imagined. She did not leave feeling permanently transformed. Instead, she noticed a subtle shift: the relentless internal pressure felt less absolute for a day or two. She was able to recognize that her thoughts were symptoms, rather than unquestionable facts.
As treatment continued, her progress was measured with more than a single question about whether she felt better. She tracked mood, sleep, anxiety, migraine frequency, daily functioning, and side effects. She also worked with her existing therapist to use the periods of improved emotional flexibility productively. That meant returning to small routines she had abandoned, such as taking walks, preparing regular meals, and accepting invitations from close friends.
By the end of her initial treatment series, Sarah still had difficult days. Her migraines had not disappeared, and she still needed ongoing mental health support. But she reported fewer mornings where getting out of bed felt impossible. She was more present with her family, better able to engage in therapy, and less consumed by the belief that nothing could help.
This distinction is clinically meaningful. Improvement may look like fewer severe symptoms, more stable functioning, better participation in therapy, or renewed capacity to make healthy choices. For some patients, relief is rapid. For others, it is gradual or incomplete. A responsible treatment plan makes room for both possibilities.
Why Ongoing Care Matters
Ketamine-based care works best when it is part of a broader plan rather than treated as a stand-alone answer. Depending on the patient, that plan may include medication management, psychotherapy, sleep support, pain treatment, nutrition assessment, movement appropriate to the person’s condition, and follow-up monitoring.
For Sarah, maintenance planning became an important conversation. She and her providers reviewed whether and when additional treatments might be considered based on symptoms and function, rather than scheduling care indefinitely without reassessment. They also monitored for changes in blood pressure, mood instability, substance-use concerns, and medication interactions.
There are practical trade-offs as well. Ketamine care may require transportation, time away from work, and an out-of-pocket financial investment. Spravato involves structured visits and observation after administration. Patients should feel comfortable asking direct questions about cost, frequency, expected monitoring, and how a provider will determine whether the treatment is helping.
A Different Question After Standard Care Falls Short
The most helpful question for someone with treatment-resistant depression is often not, “Why haven’t I found the one thing that fixes this?” A better question may be, “What has not been fully understood, and what evidence-informed options have not yet been thoughtfully considered?”
Depression that has persisted through previous treatment deserves compassion, not dismissal. With a comprehensive evaluation and a plan tailored to the whole person, many patients can find a path toward more manageable days, deeper engagement, and a renewed sense that life can expand again.
